SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-133850
Filing Date
2016-07-25
Accepted
2016-07-25 17:08:13
Documents
1
Period of Report
2016-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22611
  Complete submission text file 0001209191-16-133850.txt   24003
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
SILVERSTEIN JONATHAN (Reporting) CIK: 0001171005 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37833 | Film No.: 161782619

Mailing Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)